Literature DB >> 6191724

Pemphigus antibodies fixation and keratinocyte differentiation in organ cultures. Effects of some agents influencing the intracellular content of cyclic AMP.

E Sbano, L Andreassi, M Fimiani, R Baiocchi, M Biagioli.   

Abstract

The effect of some agents, influencing the cyclic adenosine 3', 5'-monophosphate (cAMP) content of human cells, on the ability of the keratinocytes of binding pemphigus antibodies was studied by using tissue cultures of rabbit esophagus. As demonstrated by immunofluorescence (IF) for IgG, the bound antibodies appeared markedly decreased on esophagus explants grown under standard conditions, that is without test agents, when compared to ones fixed on fresh esophagus. But the IF reaction was remarkably more intense when methylxanthines or epinephrine were added to the growth medium of the cultures. Following the addition of these agents to the cultures some histologic modifications appeared in the explants, indicating that the keratinization process had probably been stimulated. This temporal relationship of immunofluorescence and histologic findings seems to suggest the hypothesis that keratinocyte differentiation, regulation of cAMP intracellular content, and pemphigus antibodies fixation are related processes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6191724     DOI: 10.1007/bf00509022

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

1.  [The effect of cyclic AMP on the growth and differentiation of cultured epidermal cells].

Authors:  C Delescluse; M Pruniéras
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1976

2.  Adult human skin maintained in organ culture: I. The ultrastructure of the acellular compartment of connective tissue.

Authors:  B Hentzer; T Kobayasi
Journal:  Acta Derm Venereol       Date:  1979       Impact factor: 4.437

3.  Interrelationship between adenylate cyclase activity, adenosine 3':5' cyclic monophosphate phosphodiesterase activity, adenosine 3':5' cyclic monophosphate levels, and growth of cells in culture.

Authors:  W B Anderson; T R Russell; R A Carchman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

4.  Levels of cyclic AMP in sparse and dense cultures of growing and quiescent 3T3 cells.

Authors:  W Seifert; D Paul
Journal:  Nat New Biol       Date:  1972-12-27

5.  Regulation of cell growth by cyclic adenosine 3',5'-monophosphate. Effect of cell density and agents which alter cell growth on cyclic adenosine 3',5'-monophosphate levels in fibroblasts.

Authors:  J Otten; G S Johnson; I Pastan
Journal:  J Biol Chem       Date:  1972-11-10       Impact factor: 5.157

6.  Conditions leading to enhanced response to glucagon, epinephrine, or prostaglandins by adenylate cyclase of normal and malignant cultured cells.

Authors:  M H Makman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-09       Impact factor: 11.205

7.  Alteration of subcultured keratinocytes to a keratinizing epithelium.

Authors:  F W Bauer; R M de Grood
Journal:  Br J Dermatol       Date:  1973-07       Impact factor: 9.302

8.  Pemphigus antibody action on skin explants: kinetics of acantholytic changes and stability of antigens in tissue cultures of normal monkey skin explants.

Authors:  J S Deng; E H Beutner; S Shu; T P Chorzelski
Journal:  Arch Dermatol       Date:  1977-07

9.  Effects of dibutyryl adenosine 3',5'-cyclic monophosphate on human melanocytes in vitro.

Authors:  Y Kitano
Journal:  Acta Derm Venereol       Date:  1976       Impact factor: 4.437

10.  Expression of adenylate cyclase, catecholamine receptor, and cyclic adenosine monophosphate-dependent protein kinase in synchronized culture of Chang's liver cells (S phase-membrane receptors-NaF stimulation).

Authors:  M H Makman; M I Klein
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

View more
  1 in total

1.  Platelet-derived factors enhance pemphigus acantholysis in skin organ cultures.

Authors:  T Hunziker; U E Nydegger; P G Lerch; J D Vassalli
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.